Update: Neumora's IPO went effective March 26, 2025 (NasdaqGS:NMRA).
A PRELIMINARY IPO filing yesterday by Massachusetts-based Neumora Therapeutics lists among company advanta.... Read More
Editor's note: This SPAC S-1 was administratively declared abandoned by SEC staff in November 2022.-Ed.
NASHVILLE serial healthcare entrepreneur and investor Charles N. "Charl.... Read More